I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when given in combination, do not cause serious side effects, and whether the study treatment will make radioiodine therapy work better in patients with BRAF-mutant thyroid cancers.
absolute neutrophil count
plat
pet/ct
coagulation therapy
lipase
- 0 views
- 19 Feb, 2024